Riccardo Milani
/
AFP via Getty Images
The incident is the latest eyebrow-raising bet on Polymarket, as allegations of rigging and manipulation continue to haunt the popular prediction market site.
-
AI companies are under growing scrutiny over the potential harms chatbots can pose amid investigations into how mass shooters allegedly sought advice from the tools.
-
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. -
NPR's Ailsa Chang talks with Amy Jaecker-Jones of the Natural History Museum of Los Angeles County about a worldwide community science project happening this weekend — the City Nature Challenge.
-
The cuts follow losses in two pivotal court cases and the company's push to invest in artificial intelligence. -
Malaria hot spots have played a critical role in shaping where humans settled and either thrived or failed to thrive.
-
AI is threatening the availability of entry-level work. -
A revolutionary new drug could prolong and improve the quality of life for those suffering from one of the world's deadliest cancers.
-
A new study looks at an unexpected force that played a critical role in shaping the lives of ancient humans. -
Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which includes drugs like ketamine, Tylenol with codeine and anabolic steroids. -
After a year without data, the State Department released figures on PEPFAR, the program launched by George W. Bush and credited with saving millions of lives. How did Trump's aid cuts affect it?
